Collections

Filters ​

  • Focal Point |

    A large investor in R&D, South Korea’s culture of early technology adoption, combined with its strong computing infrastructure and biological research strengths, make the country an obvious personalized medicine testbed.

    Image: © John M Lund Photography Inc/Digital Vision/Getty

  • Focal Point |

    Japan is breaking ground in areas the rest of the world will soon be addressing: old age, cancer, neuroscience. The tiny weapon of choice to defeat these diverse threats is nanomedicine.

    Image: © GiroScience / Alamy Stock Photo

  • Focal Point |

    Asia is shaping up to be a vaccine powerhouse. The signs are there in funding levels, and combined with Asian governments’ interest in biotechnology, and a highly skilled, highly educated workforce, pharma giants are looking east.

    Image: © Maria Toutoudaki/Photodisc/Getty

  • Focal Point |

    From devastation to innovation How Kobe rebuilt itself after a devastating earthquake and turned into a biotechnology hub

    Image: Joe Hockel / EyeEm/Getty Images

  • Focal Point |

    In a bold new programme, the Japanese government has picked three universities to participate in a scheme designed to inject new life into Japan’s national universities. The Designated National University initiative will provide additional funding and cut red tape, making it easier for universities to develop alternate income streams, attract top researchers and students and to collaborate with industry. The three universities – Kyoto University, Tohoku University and The University of Tokyo – will be trail blazers, leading the way for other universities to follow.

    Image: Lorand Fenyes/Stocktrek Images/Getty Images

  • Focal Point |

    The space industry is undergoing a profound shift from being exclusively sponsored by governments to increasingly seeing participation by commercial entities. Dubbed ‘new space’, Japan is keen to embrace this movement. This focal point contains specific examples of companies that are seeing opportunities in space.

    Image: Lorand Fenyes/Stocktrek Images/Getty Images

  • Focal Point |

    As artificial intelligence makes headway in genomic medicine, collecting, storing, curating and processing masses of genetic information is becoming an enormous, data-intensive task. Some countries, such as Japan, must collect a huge amount of genetic information from their populations to provide the best future healthcare. Who will do this work? What will technology companies be able to add? And, how will the medical and IT industries deal with their inevitable new partnership?

    Image: KTSDESIGN/SCIENCE PHOTO LIBRARY/Getty